No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 482 contracts
Samples: Securities Purchase Agreement (La Rosa Holdings Corp.), Securities Purchase Agreement (La Rosa Holdings Corp.), Securities Purchase Agreement (ETHEMA HEALTH Corp)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 44 contracts
Samples: Securities Purchase Agreement (Arch Therapeutics, Inc.), Securities Purchase Agreement (Arch Therapeutics, Inc.), Securities Purchase Agreement (Arch Therapeutics, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings SEC Documents and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 15 contracts
Samples: Securities Purchase Agreement (Resonate Blends, Inc.), Securities Purchase Agreement (SusGlobal Energy Corp.), Securities Purchase Agreement (Kaival Brands Innovations Group, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off off- balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 12 contracts
Samples: Securities Purchase Agreement (Blue Star Foods Corp.), Securities Purchase Agreement (SIMPLICITY ESPORTS & GAMING Co), Securities Purchase Agreement (SIMPLICITY ESPORTS & GAMING Co)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Material Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 8 contracts
Samples: Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.), Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.), Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Exchange Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (Mphase Technologies, Inc.), Securities Purchase Agreement (Jerrick Media Holdings, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings Commission Documents and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Convertible Preferred Stock and Warrant (AzurRx BioPharma, Inc.), Convertible Note and Warrant Purchase Agreement (AzurRx BioPharma, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings SEC Reports and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (iQSTEL Inc), Securities Purchase Agreement (Snail, Inc.)
No Off Balance Sheet Arrangements. There Except as set forth in the SEC Documents, there is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Securities Purchase Agreement (iCoreConnect Inc.), Securities Purchase Agreement (iCoreConnect Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in 13 its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.. β
Appears in 1 contract
Samples: Securities Purchase Agreement (Electromedical Technologies, Inc)
No Off Balance Sheet Arrangements. There Except as reflected in the SEC Documents, there is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (INVO Bioscience, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and that is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries subsidiaries and an unconsolidated or other off balance sheet entity that the Company is required to be disclosed by the Company disclose in its 1934 Act filings and is not so disclosed disclosed, or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (FiscalNote Holdings, Inc.)
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its 1934 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
No Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company or any of its Subsidiaries and an unconsolidated or other off off-balance sheet entity that is required to be disclosed by the Company in its 1934 β34 Act filings and is not so disclosed or that otherwise could be reasonably likely to have a Material Adverse Effect.
Appears in 1 contract
Samples: Securities Purchase Agreement (NuLife Sciences, Inc.)
